Mentions
Extended reach
Total likes
Video views
AI synopsis
Overall, these discussions reflect a strong consensus on the alarming immune evasion capabilities of the BQ and XBB variants, referencing multiple scientific studies and emphasizing the threats to current vaccines. The tone varies from alarmed to skeptical, with many examples highlighting how the variants can render treatments and vaccines less effective, which underscores their high potential impact on public health and vaccine strategies.
Most discussions acknowledge the seriousness of the variants' immune evasion abilities, aligning with the article's findings.
Posts demonstrate high curiosity, sharing detailed studies, conflicting viewpoints, and emphasizing the consequences of immune escape.
Numerous discussions reference specific scientific papers, highlight implications for vaccine efficacy, and debate public health responses.
The widespread concern expressed suggests this issue significantly influences ongoing debates about COVID-19 policies and vaccine strategies.
BQ及びXBBに対する血清中和抗体価は、従来ウイルスD614Gと比較して、各13〜81倍、66〜155倍低下し、既存のワクチンや感染による免疫能が低下 認可されたモノクローナル抗体製剤も無効 Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants https://t.co/QUSwIgNlxv https://t.co/sZDlFyKdDa
@IanCopeland5 Or this study about immune evasion by the more recent subvariants, with these comments. /2 https://t.co/xts4Y51CrZ https://t.co/JSxwyDRuZS
In the latest issue! Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants https://t.co/Iqlk1QnKo2
Otro estudio muestra que las personas que han sido vacunadas varias veces están particularmente en riesgo. Cuanto más a menudo alguien se vacunaba contra Corona, más bajas eran sus defensas contra los nuevos virus Corona. https://t.co/wooU3m6nbv
"Our findings indicate that BQ and XBB subvariants present serious threats to current COVID-19 vaccines, render inactive all authorized antibodies, and may have gained dominance in the population because of their advantage in evading antibodies." https://t.co/CMgbPjQR9K
Menos mal que la respuesta celular es la más potente y duradera. Muestran que la neutralización de BQ.1, BQ.1.1, XBB y XBB.1 por sueros de vacunados e infectados fue afectada, incluidos reforzados con vacuna de ARNm bivalente WA1/BA.5 https://t.co/8s0ar1c80w
The BQ and XBB subvariants of SARS-CoV-2 Omicron are spreading rapidly because they have new mutations in their spike proteins that make them better at evading immunity from vaccines and previous infections.
Respiratory infections are the leading cause of death from infectious diseases globally, making accurate diagnosis crucial. The researchers developed DNA nanobait technology that can identify multiple respiratory…
RT @DrMarcSiegel: Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants: Cell - XBB is now over 40 percent of th…
Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants https://t.co/rMYvC7G7cU
@GeorgeMonbiot @NateB_Panic https://t.co/FLhdv8vkTr https://t.co/T2GfQ1BJzy
Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants https://t.co/N3ccIbvHJS 2022
@ShiraDoronMD @EWidera Even experts have done it: "Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants" https://t.co/XvblmnTAcQ
@Pegasus311 えっと、この動画 https://t.co/n8uqrKAO9k で紹介されているこの論文 「Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants」 https://t.co/AsojVBCBHe のことですかね? ここでは、XBB.1 が Omicron サブバリアントの中で最も抗原的に異なる。
Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants https://t.co/McqIyXnf7h
RT @ma_pion:
コロナ2価ワクチンはXBB型に効果なし。武漢型やBA2型ワクチンを何度も打った人はXBB単価ワクチンの効果なし。 Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants: Cell https://t.co/mjIviB4uCp https://t.co/iAb85nKaAs
https://t.co/jC5lgr3OYU 重要論文！急増するSARS-CoV-2 BQおよびXBB亜系統の驚くべき抗体回避特性 Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants Qian Wang, et al. WA1/BA.5二価mRNAワクチンでブースター接種をした人の血清も含め，
2023/07/01 オミクロンの新しい亜種（BQおよびXBB）は抗体を回避する Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants 増加するSARS-CoV-2 BQおよびXBB亜種の警戒すべき抗体回避特性 https://t.co/vNKlZA1FXh
鹿先生 ●永遠に無効なコロナワクチン https://t.co/2ebPCfbQzY https://t.co/mNkLwTAEzb https://t.co/9wugj70X3B%
https://t.co/dakr4PaWO6 増加する SARS-CoV-2 BQ および XBB サブバリアントの驚くべき抗体回避特性 https://t.co/BcLsIAVQYn
｢百害あって一利なし｣の
Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants https://t.co/ph9OCNEzvR
@ryanbeed @MayassiSabia @zwergie1 @sleightHanded @ptcjoneses @Opportunitweet @snorman1776 @jeffreyatucker @19joho From another perspective: "Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants" https://t.co/xts4Y51CrZ https://t.co/cX8CM935fL
RT @jhillmd: “BQ and XBB subvariants present serious threats to current COVID-19 vaccines, render inactive all authorized antibodies, and m…
“BQ and XBB subvariants present serious threats to current COVID-19 vaccines, render inactive all authorized antibodies, and may have gained dominance in the population because of their advantage in evading antibodies.” https://t.co/aSi509Fmjb
RT @dr_cottrell: https://t.co/UG3NbNShKM
RT @dr_cottrell: https://t.co/UG3NbNShKM
RT @dr_cottrell: https://t.co/UG3NbNShKM
https://t.co/UG3NbNShKM
@loquat_priest @DrMagicianEARL sotrovimabがIC50の観点から比較的マシ？に見える話はちょいちょいありますよね https://t.co/Nct3i04VGr
@cclareMDMPH Just curious, what do you think gets boosted by these shots, professor? Because all the latest research shows its definitely not functional antibodies... https://t.co/OQofEGWVPI https://t.co/xQMEFbHD1c https://t.co/lGjm7IcopB https://t.co/nrrnkm6p9M
ที่น่ากลัวคือ Variant BQ, XBB มันหลบภูมิสร้างจาก mRNA ทั้ง ตัวหลัก และ Bivalent ที่มีใช้ในตลาดขณะนี้ https://t.co/FHMbpcqM6y
@dragonfishy Thanks, Doc! There's an abundance of studies that show that immune imprinting is driving large scale immune escape. Govs won't act. We have to make the unjabbed aware, so they can protect jabbed loved ones! https://t.co/EPBVb5pNA0 https://t.co/0ydjXl2yLt https://t.co/OQofEGWVPI https://t.co/EUL9gf0Zyw
RT @_LeMoog_: Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants https://t.co/wFXCK7bJA2
@BarryESharp @tigresseleanor @Sharky_vs_Evil The variants still haven’t evaded the antibodies https://t.co/OxWGVi0pa6
@BarryESharp @Sharky_vs_Evil @tigresseleanor It was nowhere near as immune evasive as Omicron and even with Omicron the vaccines work. Too hard for your feeble mind to comprehend https://t.co/OxWGVi0pa6
@Food4ears @MarKes1900 @howling_yoda @ReinoManssen @mkeulemans @MarcBonten @Rob_Roos @MarionKoopmans @_knaw @RHDijkgraaf https://t.co/0z8S4UAFeS Over vaccinschade mag je hier op je kop staan, het bestaat. Over de evolutie van de pandemie weet je geen bal, ik ook niet... we zullen wel zien of Geert vanden Bossche zijn claims uitkomen. Maar hem wegezetten als charlatan, belachelijk John
Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants - ScienceDirect https://t.co/fvpuutowkN
@Debunk_the_Funk @GuyPers71853683 @TheEsotariq @swamp_ist @GVDBossche They aren't? That would news to many researchers and experts. "Alarming antibody evasion" https://t.co/xts4Y51CrZ "Predominance of antibody-resistant SARS-CoV-2 variants in vaccine breakthrough cases" https://t.co/BjV7ir4wBS /1 https://t.co/azVk2CKzKR
@potculturedotca @MadLadMarcin @AngelGarciaMon8 @realChasDarwin @CanuckFromSK @JustinTrudeau Thank you for adding to what I said. Those numbers are not even close to 90% and against older sub variants. The newer sub variants are even more immunity evasive. "Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants" https://t.co/xts4Y51CrZ https://t.co/jtnRwDjF4G
Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants - ScienceDirect https://t.co/SGEdCpsnLP
RT @CellPressNews: "Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants" @CellCellPress https://t.co/nsmXIC0z…
RT @AbraarKaran: "Together, our findings indicate that BQ and XBB subvariants present serious threats to current COVID-19 vaccines, render…
@arikouts @OrHekto @SenseurFR @a314116r https://t.co/SeZQJRLTTk Cela,se complique cher ami
@Debunk_the_Funk @SJayToday And, once again, the conclusions of those studying both the newer variants and the effects of the virus. Coming to similar conclusions. Quit living on past accolades and come into the present funk. https://t.co/RoVjRuiB8E https://t.co/xts4Y51CrZ https://t.co/AtaKvmcw0q
@Debunk_the_Funk @IanCopeland5 Well, since I am here I will also add the remarks from the two studies, showing similar concerns from different angles. https://t.co/xts4Y514Cr https://t.co/RoVjRui3j6 https://t.co/dUDCtS0c6X
https://t.co/jjFvPwJGzT
@musikutiv @sankari83 @throeng @tomdabassman https://t.co/jjFvPwJGzT
RT @norionakatsuji: 新たに感染拡大している新型コロナウイルス変異株が、今使われているワクチンや中和抗体による抑制効果から免れるだろう、という心配な最新研究結果のCell誌論文はこれだな。 “Alarming antibody evasion properti…
Foremost may be their extreme antibody evasion properties, especially considering the extensive herd immunity built up in the population over the last three years from infections and vaccinations. https://t.co/HzoPsGqFi1
The combination of mAbs known as Evusheld that is authorized for the prevention of COVID-19 is also completely inactive against the new subvariants. This poses a serious problem for millions of immunocompromised individuals. https://t.co/HzoPsGqFi1
Therefore, it is alarming that these newly emerged subvariants could further compromise the efficacy of current COVID-19 vaccines and result in a surge of breakthrough infections as well as re-infections. https://t.co/HzoPsGqFi1
Our data demonstrate that these new subvariants were barely susceptible to neutralization by sera from vaccinated individuals with or without prior infection, including persons recently boosted with the new bivalent (WA1/BA.5). https://t.co/6KOVmWh6DE
Our data demonstrate that these new subvariants were barely susceptible to neutralization by sera from vaccinated individuals with or without prior infection, including persons recently boosted with the new bivalent (WA1/BA.5) https://t.co/HzoPsGqFi1
The BQ and XBB subvariants of SARS-CoV-2 Omicron are now rapidly expanding, possibly due to altered antibody evasion properties deriving from their additional spike mutations. https://t.co/HzoPsGqFi1
Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants. https://t.co/HzoPsGqFi1
RT @AbraarKaran: "Together, our findings indicate that BQ and XBB subvariants present serious threats to current COVID-19 vaccines, render…
@maggiemae362 @alexmeshkin Yes. And this one. https://t.co/dVQ4IoxlfJ
@redwondereroft1 @IanCopeland5 Blocked. For anyone not trying to be argumentative. This is what they say at the end of the discussion. https://t.co/xts4Y51CrZ https://t.co/RFi3s8E5V6
@redwondereroft1 @IanCopeland5 No. You are ignoring what I just said and the evidence from newer studies with current sub variants. Like the Cleveland Clinic study and others that look at Ab levels. Like this one. That ended with this: https://t.co/xts4Y51CrZ https://t.co/djS7KBIfx9
@IanCopeland5 Or this study about immune evasion by the more recent subvariants, with these comments. /2 https://t.co/xts4Y51CrZ https://t.co/JSxwyDRuZS
@ScottTheRockS @PierreJoliat @KhNyMd @realstewpeters There are several studies concerned about the evolution immune evasion of newer subvariants. Evolution that may actually be accelerated or driven by the vaccines. /2 https://t.co/xts4Y51CrZ https://t.co/EDiz4HoK1v
RT @manuelmuro5: Menos mal que la respuesta celular es la más potente y duradera. Muestran que la neutralización de BQ.1, BQ.1.1, XBB y XBB…
RT @manuelmuro5: Menos mal que la respuesta celular es la más potente y duradera. Muestran que la neutralización de BQ.1, BQ.1.1, XBB y XBB…
RT @manuelmuro5: Menos mal que la respuesta celular es la más potente y duradera. Muestran que la neutralización de BQ.1, BQ.1.1, XBB y XBB…
@cbotnyse @Freeyourmindkid Who “we” got lucky? Those who died with/because of? Those who continue suffering the effects months/years later? Those immunocompromised trapped in a no where to go landscape? And who said the variants were mild? Shameful is @mtosterholm
RT @manuelmuro5: Menos mal que la respuesta celular es la más potente y duradera. Muestran que la neutralización de BQ.1, BQ.1.1, XBB y XBB…
Menos mal que la respuesta celular es la más potente y duradera. Muestran que la neutralización de BQ.1, BQ.1.1, XBB y XBB.1 por sueros de vacunados e infectados fue afectada, incluidos reforzados con vacuna de ARNm bivalente WA1/BA.5 https://t.co/8s0ar1c80w
Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants - Cell https://t.co/1elcSiT5QX Volume 186, Issue 2, 19 January 2023, Pages 279-286.e8 https://t.co/5LGL64fiMY
which it was an article in the Cell,"Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants".
@DannySports86 @pamelaad116 @DrEricDing flu is a respiratory virus. Vaccines were created for wild type. Bivalents addressed Omicron variants B4/5. Now, 50% of sequenced cases are XBB.1.5. -vaccines do not stop transmission -no therapeutics work for new variants -2000+ deaths/week We are back https://t.co/4obJAUV0FG https://t.co/YDhkvatsPH
RT @RealCheckMarker: #Incurable In case anyone was unaware the XBB and BQ variants changed the effectiveness of bivalent vaccines: "Alarmi…
#Incurable In case anyone was unaware the XBB and BQ variants changed the effectiveness of bivalent vaccines: "Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants" https://t.co/bBmQoNQ3b8 https://t.co/TG2RAaWPHt
@Debunk_the_Funk @LacBougie @DohoGg @DrSyedHaider Just to make this complete, the warnings from papers I have asked you to *debunk* if you can. Is @InWuchang right? Can you say nothing negative about the current vaccines? https://t.co/RoVjRuiB8E https://t.co/xts4Y51CrZ https://t.co/uSNY9K3QgM
RT @AbraarKaran: "Together, our findings indicate that BQ and XBB subvariants present serious threats to current COVID-19 vaccines, render…
But do they go far enough. Are we acknowledging the warnings being posed by those who are looking at the new variants? https://t.co/RoVjRuiB8E https://t.co/xts4Y51CrZ https://t.co/11tQiDNg9d
@LSuperfriends @ptcjoneses Did they? Or are they trying to sound an alarm like these authors. The virus has been steps ahead of us all along. https://t.co/xts4Y51CrZ https://t.co/UfRswi9CdC
RT @lgoshen: @UllmannMdB Welche Basisimmunität? In den USA sorgt eine weitere Immune-Escape-Variante (#XBB15) dafür, dass die Covid-Hospita…
RT @CellCellPress: In the latest issue! Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants https://t.co/Iqlk1…
RT @MIGUELA71643080: "Nuestros hallazgos indican que las subvariantes BQ y XBB presentan serias amenazas para las vacunas COVID-19 actuales…
RT @MIGUELA71643080: "Nuestros hallazgos indican que las subvariantes BQ y XBB presentan serias amenazas para las vacunas COVID-19 actuales…
@LSuperfriends @ptcjoneses And both of these are against variants that are no longer dominant. You and your buddies want to live in the past and not acknowledge studies agains newer variants. Why is that? https://t.co/CCslCic6Ty https://t.co/v5iXXtUcRb https://t.co/xts4Y51CrZ
RT @AbraarKaran: "Together, our findings indicate that BQ and XBB subvariants present serious threats to current COVID-19 vaccines, render…
RT @jathorpmfm: "Our findings indicate that BQ and XBB subvariants present serious threats to current COVID-19 vaccines, render inactive al…
"Our findings indicate that BQ and XBB subvariants present serious threats to current COVID-19 vaccines, render inactive all authorized antibodies, and may have gained dominance in the population because of their advantage https://t.co/qOLsobnTx9 https://t.co/9HkZtdH77g
@ptcjoneses @BurgerLab12 @SkepticalMutant @volpiranyas @GiveABJGoToJail @Scary7Dr @nopoisonjabs @MaureenStroud @TackettWendi @pawley_robert @LouforFreedomL1 @Nicoleg425 @zee_parody @provaxtexan @JimeeLiberty @Pouldeau61 @real_seeking @AndrewLazarus4 @scottstocker4 @ogilville1 @tomsirolimus @ryanbeed @GOPMama71 @Monstercoyliar @AspAlaAsnAsnTyr @WendyOrent @mcfunny @ConsequentialBr @Nockit1 @TonyBaduy @doom37455413 @JKelleyK @tarsins @IdunsDaughter @ZeetubesII @IncitatusAlpha @kevinault @richykirsh @nuhope2022 @Thskicksarefire @JohannaSzabo1 @Nicky111Lady @reacharoundu @doritmi @kberkopes @i_am_joli_anne @AngryFleas @jarbot15 @barryjohnreid21 @ShadowDroid616 He obviously didn't catch the three problems shown above. All of these vax zealots are chasing to live in the pass and ignore the newer evidence against the sub variants gaining dominence. Like this study with it's conclusion. https://
@tuckersleftnut Uh oh. Certainly not ineffective antibodies. Now how could that happen? Should I prepare myself for more slander and yelling. Sniff. Sniff. Muh feelings. https://t.co/UqzcchdMXg
@btysonmd "..our findings indicate..BQ and XBB subvariants present serious threats to current COVID-19 vaccines, render inactive all authorized antibodies, and may have gained dominance in the population because of their advantage in evading antibodies." https://t.co/w1XRHtYtk1 https://t.co/DoxjhuuUR3
RT @jathorpmfm: "Our findings indicate that BQ and XBB subvariants present serious threats to current COVID-19 vaccines, render inactive al…
RT @jathorpmfm: "Our findings indicate that BQ and XBB subvariants present serious threats to current COVID-19 vaccines, render inactive al…
"Nuestros hallazgos indican que las subvariantes BQ y XBB presentan serias amenazas para las vacunas COVID-19 actuales, inactivan todos los anticuerpos autorizados y pueden haber ganado dominio en la población debido a su ventaja para evadir anticuerpos". https://t.co/uzdlQvBMcd
RT @jathorpmfm: "Our findings indicate that BQ and XBB subvariants present serious threats to current COVID-19 vaccines, render inactive al…
RT @jathorpmfm: "Our findings indicate that BQ and XBB subvariants present serious threats to current COVID-19 vaccines, render inactive al…
"Our findings indicate that BQ and XBB subvariants present serious threats to current COVID-19 vaccines, render inactive all authorized antibodies, and may have gained dominance in the population because of their advantage in evading antibodies." https://t.co/CMgbPjQR9K
COVID variant Dominance via Antibody Evasion! Selection Pressures rewrite the code! Yet the Pharma Bums & their Government Accessories will not
@Debunk_the_Funk @TimTrippDesign @ScottAdamsSays You still refuse to acknowledge recent studies that have come to the conclusion that we need new treatment paradigms. You are living in the past. https://t.co/xts4Y51CrZ https://t.co/RoVjRuiB8E https://t.co/2jnetHDViu
RT @AbraarKaran: "Together, our findings indicate that BQ and XBB subvariants present serious threats to current COVID-19 vaccines, render…
@KnopkeAndreasMD Ist ja schon eher bewiesen, oder? Die Genimpfstoffe sind immunologisch quasi Subunit-Impfstoffe und wirken deswegen sehr spezifisch gegen einzelne Varianten. Die angepassten Impfstoffe wurden bereits nach wenigen Wochen mit #XBB15 "beantwortet" https://t.co/Ox8HcRcFZv
RT @CellCellPress: In the latest issue! Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants https://t.co/Iqlk1…
RT @AeroMedicine: Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants. Via @CellPressNews #pandemic #subvaria…
Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants: Cell https://t.co/0ON35kLkKE
Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants: Cell https://t.co/2ygVIbokxl
Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants https://t.co/g3VYG2EICH https://t.co/x9D3kdSL3z
https://t.co/ColEyNLyNP
"Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants" ➡️Limited artificial studies to say for sure. ➡️Cellular immunity was not investigated. Results as expected as can be, nothing alarming! Same story different publication... https://t.co/9PCkLUOtyO
CELL Vol. 186 No. 2 https://t.co/ggugF5nUtt Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants Wang et al.
RT @CellCellPress: In the latest issue! Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants https://t.co/Iqlk1…
RT @CellCellPress: In the latest issue! Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants https://t.co/Iqlk1…
In the latest issue! Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants https://t.co/Iqlk1QnKo2
@kengold @vitomendy3 @DrEricDing You can believe that if you want. You probably need to since you have been jabbed so many times. But, imo, the evidence for the new subvariants is not good. / https://t.co/frfU2mK48e https://t.co/v5iXXtUcRb https://t.co/CCslCic6Ty https://t.co/xts4Y51CrZ
Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB s... https://t.co/0qI9b8eknG
Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB s... https://t.co/0qI9b8eSde
RT @MIGUELA71643080: Otro estudio muestra que las personas que han sido vacunadas varias veces están particularmente en riesgo. Cuanto más…
RT @MIGUELA71643080: Otro estudio muestra que las personas que han sido vacunadas varias veces están particularmente en riesgo. Cuanto más…
RT @MIGUELA71643080: Otro estudio muestra que las personas que han sido vacunadas varias veces están particularmente en riesgo. Cuanto más…
RT @MIGUELA71643080: Otro estudio muestra que las personas que han sido vacunadas varias veces están particularmente en riesgo. Cuanto más…
@sozialbehoerde @_monocode_ @Senat_Hamburg @fuw_hh Quellen: 1. https://t.co/CLxxamZu4s 2. https://t.co/hWQqs5XzG5
Otro estudio muestra que las personas que han sido vacunadas varias veces están particularmente en riesgo. Cuanto más a menudo alguien se vacunaba contra Corona, más bajas eran sus defensas contra los nuevos virus Corona. https://t.co/wooU3m6nbv
RT @gorka_orive: 5. Un estudio observa que las variantes BQ.1, BQ.1.1, XBB, y XBB.1 son las más resistentes hasta el momento y evasivas inm…
RT @gorka_orive: Un estudio observa que las variantes BQ.1, BQ.1.1, XBB, y XBB.1 son las más resistentes hasta el momento y evasivas inmuno…
RT @villagerssn: @EricTopol @BarouchLab @NEJM Funny that your *summary* of the available data doesn't include this Cleveland Clinic study w…
@EricTopol @BarouchLab @NEJM Funny that your *summary* of the available data doesn't include this Cleveland Clinic study whose first author is a highly published ID doctor. https://t.co/jpLEoZustl Or discuss any of the studies about newer variants like this one. Some summary. https://t.co/xts4Y51CrZ
RT @carpe_diem0820: BQ及びXBBに対する血清中和抗体価は、従来ウイルスD614Gと比較して、各13〜81倍、66〜155倍低下し、既存のワクチンや感染による免疫能が低下 認可されたモノクローナル抗体製剤も無効 Alarming antibody evas…
RT @GosiaGasperoPhD: Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants. When scientists use the word ‘alarm…
RT @michaelzlin: Discussion of the paper "Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants" "When scientis…
Subvariantes BQ y XBB subvariantes de SARS-CoV-2 demuestran dramáticamente + capacidad para evadir la neutralización por anticuerpos, incluso en personas con refuerzo bivalente o posterior a infección. Wang Q, et al. Dec, 2022. doi:10.1016/j.cell.2022.12.018. https://t.co/dTQooodjsA
RT @michaelzlin: Discussion of the paper "Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants" "When scientis…
RT @MarcGozlan: Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants. "Our findings indicate that BQ and XBB su…
RRIDs were included in the Cell paper "Alarming antibody evasion properties of rising SAR…" (https://t.co/BCxGbxH1vN). RRIDs like this improve reproducibility in scientific research. #methodsmatter #ReproducibleResearch
@MaryanneDemasi "...neutralization of BQ.1, BQ.1.1, XBB, and XBB.1 by sera from vaccinees and infected persons was markedly impaired, including sera from individuals boosted with a WA1/BA.5 bivalent mRNA vaccine." https://t.co/GWkqsXUlBq
RT @gorka_orive: Un estudio observa que las variantes BQ.1, BQ.1.1, XBB, y XBB.1 son las más resistentes hasta el momento y evasivas inmuno…
RT @TactNowInfo: @SpartaJustice XBB subvariants present serious threats to current COVID vaccines, render inactive all authorized antibodie…
@POTUS "...we report that neutralization of BQ.1, BQ.1.1, XBB, and XBB.1 by sera from vaccinees and infected persons was markedly impaired, including sera from individuals boosted with a WA1/BA.5 bivalent mRNA vaccine." https://t.co/GWkqsXUlBq
RT @AbraarKaran: "Together, our findings indicate that BQ and XBB subvariants present serious threats to current COVID-19 vaccines, render…
RT @VCSTX:
RT @VCSTX: #Sequencing pathogens is key for #publichealth. In the case of #SARSCov2 virus, it is essential to know which #variants are mo…
RT @cygnus_321: In layman’s language, XBB.1.5 is the equivalent of an entirely new variant. (https://t.co/EAaG5vTL39) https://t.co/bimWq8E…
In layman’s language, XBB.1.5 is the equivalent of an entirely new variant. (https://t.co/EAaG5vTL39) https://t.co/bimWq8EWSa
RT @gorka_orive: 5. Un estudio observa que las variantes BQ.1, BQ.1.1, XBB, y XBB.1 son las más resistentes hasta el momento y evasivas inm…
Not over: "Alarming antibody evasion properties of rising SARS-CoV-2 BQ & XBB subvariants" @CellPressNews - Serum neutralization markedly reduced incl w bivalent booster - All clinical monoclonal antibodies rendered inactive against these variants https://t.co/bx9bxYXvjk
RT @gorka_orive: 5. Un estudio observa que las variantes BQ.1, BQ.1.1, XBB, y XBB.1 son las más resistentes hasta el momento y evasivas inm…
I don't recall an article from Cell that starts with the word, "alarming". "Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants." https://t.co/GtPCPlQSAG
Un reciente estudio indica que Kraken goza de 49 veces más probabilidades de escapar a los anticuerpos generados por la vacuna de ómicron (63 veces en caso de las primeras vacunas). Aún así, insistimos, no hay indicios de que cause enfermedad más grave. https://t.co/zJmKWWdEuR https://t.co/IZRlQUumcv
Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants https://t.co/C1zWynGf5K
RT @AeroMedicine: Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants. Via @CellPressNews #pandemic #subvaria…
@BennyisHere_215 @VGrubsky My current thought goes along with the conclusions from two very different papers. The new sub variants are acting very different from those most studies deal with, they are evading immunity from both infection and vaccines. / https://t.co/xts4Y51CrZ https://t.co/jpLEoZustl https://t.co/luEWIkz4mi
@jamie_reinhold @david_shane @RimaForAAPS That’s true, so hopefully that will provide reduced severity of accidental infections. It’s concerning that the XBB1.5 variant has both greater immune escape and tighter ACE2 binding. Clean air and avoiding inhalation of aerosols works for all variants. https://t.co/sciSva12ln
@gco60361907 @JReinerMD You will likely be waiting a long time. None of the vaxx zealots seem to want to talk about these studies. "Neutralisation sensitivity of the SARS-CoV-2 XBB.1 lineage" https://t.co/CCslCic6Ty https://t.co/xts4Y51CrZ
RT @gorka_orive: 5. Un estudio observa que las variantes BQ.1, BQ.1.1, XBB, y XBB.1 son las más resistentes hasta el momento y evasivas inm…
@VGrubsky Likely plays a big part in many things these days. Evidence seems to suggest the new variants evade immunity from both vaccines and infection. "Neutralisation sensitivity of the SARS-CoV-2 XBB.1 lineage" https://t.co/CCslCic6Ty This one looks at both. https://t.co/xts4Y51CrZ
RT @gorka_orive: 5. Un estudio observa que las variantes BQ.1, BQ.1.1, XBB, y XBB.1 son las más resistentes hasta el momento y evasivas inm…
RT @gorka_orive: 5. Un estudio observa que las variantes BQ.1, BQ.1.1, XBB, y XBB.1 son las más resistentes hasta el momento y evasivas inm…
RT @gorka_orive: 5. Un estudio observa que las variantes BQ.1, BQ.1.1, XBB, y XBB.1 son las más resistentes hasta el momento y evasivas inm…
RT @gorka_orive: 5. Un estudio observa que las variantes BQ.1, BQ.1.1, XBB, y XBB.1 son las más resistentes hasta el momento y evasivas inm…
RT @gorka_orive: 5. Un estudio observa que las variantes BQ.1, BQ.1.1, XBB, y XBB.1 son las más resistentes hasta el momento y evasivas inm…
Had a great time. Vaccine effectiveness in preventing mortality is high, but you're still gonna get it though... XBB is another breed. Global markets are underestimating the potential consequences of a new COVID wave. https://t.co/tzJV9ou8tu
RT @gorka_orive: 5. Un estudio observa que las variantes BQ.1, BQ.1.1, XBB, y XBB.1 son las más resistentes hasta el momento y evasivas inm…
https://t.co/jzROkoWtg3
RT @gorka_orive: 5. Un estudio observa que las variantes BQ.1, BQ.1.1, XBB, y XBB.1 son las más resistentes hasta el momento y evasivas inm…
RT @gorka_orive: 5. Un estudio observa que las variantes BQ.1, BQ.1.1, XBB, y XBB.1 son las más resistentes hasta el momento y evasivas inm…
RT @gorka_orive: 5. Un estudio observa que las variantes BQ.1, BQ.1.1, XBB, y XBB.1 son las más resistentes hasta el momento y evasivas inm…
RT @gorka_orive: 5. Un estudio observa que las variantes BQ.1, BQ.1.1, XBB, y XBB.1 son las más resistentes hasta el momento y evasivas inm…
オミクロンのBQおよびXBBは、スパイク変異の追加に由来する抗体回避性の変化により、現在急速に拡大している。BQおよびXBBは、認可されているすべての抗体を不活性化する可能性がある Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants https://t.co/3SBYYIIix1
RT @gorka_orive: 5. Un estudio observa que las variantes BQ.1, BQ.1.1, XBB, y XBB.1 son las más resistentes hasta el momento y evasivas inm…
RT @gorka_orive: 5. Un estudio observa que las variantes BQ.1, BQ.1.1, XBB, y XBB.1 son las más resistentes hasta el momento y evasivas inm…
RT @Luchostein: Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants https://t.co/SW0yHVcCYo https://t.co/kgKrn…
RT @carpe_diem0820: BQ及びXBBに対する血清中和抗体価は、従来ウイルスD614Gと比較して、各13〜81倍、66〜155倍低下し、既存のワクチンや感染による免疫能が低下 認可されたモノクローナル抗体製剤も無効 Alarming antibody evas…
RT @MarcGozlan: Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants. "Our findings indicate that BQ and XBB su…
Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants: Cell https://t.co/bjjshEPkih
Well, those Abs need a workout, apparently ... Wang et al. ‘Alarming Antibody Evasion Properties of Rising SARS-CoV-2 BQ and XBB Subvariants’. Cell, 14 December 2022. https://doi.org/10.1016/j.cell.2022.12.018.
RT @Luchostein: Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants https://t.co/SW0yHVcCYo https://t.co/kgKrn…
RT @carpe_diem0820: BQ及びXBBに対する血清中和抗体価は、従来ウイルスD614Gと比較して、各13〜81倍、66〜155倍低下し、既存のワクチンや感染による免疫能が低下 認可されたモノクローナル抗体製剤も無効 Alarming antibody evas…
Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants https://t.co/SW0yHVcCYo https://t.co/kgKrn6stqo
RT @carpe_diem0820: BQ及びXBBに対する血清中和抗体価は、従来ウイルスD614Gと比較して、各13〜81倍、66〜155倍低下し、既存のワクチンや感染による免疫能が低下 認可されたモノクローナル抗体製剤も無効 Alarming antibody evas…
RT @carpe_diem0820: BQ及びXBBに対する血清中和抗体価は、従来ウイルスD614Gと比較して、各13〜81倍、66〜155倍低下し、既存のワクチンや感染による免疫能が低下 認可されたモノクローナル抗体製剤も無効 Alarming antibody evas…
Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants https://t.co/jIHiH5EnB8
RT @carpe_diem0820: BQ及びXBBに対する血清中和抗体価は、従来ウイルスD614Gと比較して、各13〜81倍、66〜155倍低下し、既存のワクチンや感染による免疫能が低下 認可されたモノクローナル抗体製剤も無効 Alarming antibody evas…
RT @carpe_diem0820: BQ及びXBBに対する血清中和抗体価は、従来ウイルスD614Gと比較して、各13〜81倍、66〜155倍低下し、既存のワクチンや感染による免疫能が低下 認可されたモノクローナル抗体製剤も無効 Alarming antibody evas…
RT @carpe_diem0820: BQ及びXBBに対する血清中和抗体価は、従来ウイルスD614Gと比較して、各13〜81倍、66〜155倍低下し、既存のワクチンや感染による免疫能が低下 認可されたモノクローナル抗体製剤も無効 Alarming antibody evas…
Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants https://t.co/rzGL9JhbN1 The SARS-CoV-2 Omicron variant continues to evolve, with new BQ and XBB subvariants now rapidly expanding in...
RT @rsciencejournal: Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants https://t.co/JLpz0LmAuB #science #e…
RT @MarcGozlan: Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants. "Our findings indicate that BQ and XBB su…
RT @carpe_diem0820: BQ及びXBBに対する血清中和抗体価は、従来ウイルスD614Gと比較して、各13〜81倍、66〜155倍低下し、既存のワクチンや感染による免疫能が低下 認可されたモノクローナル抗体製剤も無効 Alarming antibody evas…
RT @carpe_diem0820: BQ及びXBBに対する血清中和抗体価は、従来ウイルスD614Gと比較して、各13〜81倍、66〜155倍低下し、既存のワクチンや感染による免疫能が低下 認可されたモノクローナル抗体製剤も無効 Alarming antibody evas…
RT @carpe_diem0820: BQ及びXBBに対する血清中和抗体価は、従来ウイルスD614Gと比較して、各13〜81倍、66〜155倍低下し、既存のワクチンや感染による免疫能が低下 認可されたモノクローナル抗体製剤も無効 Alarming antibody evas…
RT @carpe_diem0820: BQ及びXBBに対する血清中和抗体価は、従来ウイルスD614Gと比較して、各13〜81倍、66〜155倍低下し、既存のワクチンや感染による免疫能が低下 認可されたモノクローナル抗体製剤も無効 Alarming antibody evas…
RT @carpe_diem0820: BQ及びXBBに対する血清中和抗体価は、従来ウイルスD614Gと比較して、各13〜81倍、66〜155倍低下し、既存のワクチンや感染による免疫能が低下 認可されたモノクローナル抗体製剤も無効 Alarming antibody evas…
RT @carpe_diem0820: BQ及びXBBに対する血清中和抗体価は、従来ウイルスD614Gと比較して、各13〜81倍、66〜155倍低下し、既存のワクチンや感染による免疫能が低下 認可されたモノクローナル抗体製剤も無効 Alarming antibody evas…
RT @carpe_diem0820: BQ及びXBBに対する血清中和抗体価は、従来ウイルスD614Gと比較して、各13〜81倍、66〜155倍低下し、既存のワクチンや感染による免疫能が低下 認可されたモノクローナル抗体製剤も無効 Alarming antibody evas…
BQ及びXBBに対する血清中和抗体価は、従来ウイルスD614Gと比較して、各13〜81倍、66〜155倍低下し、既存のワクチンや感染による免疫能が低下 認可されたモノクローナル抗体製剤も無効 Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants https://t.co/QUSwIgNlxv https://t.co/sZDlFyKdDa
RT @MarcGozlan: Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants. "Our findings indicate that BQ and XBB su…
Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants - PubMed https://t.co/c1ynklUgsm
RT @MarcGozlan: Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants. "Our findings indicate that BQ and XBB su…
Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants https://t.co/1VpyGtXHuM
RT @MarcGozlan: Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants. "Our findings indicate that BQ and XBB su…
Coronavirus: Alarming antibody evasion properties of rising SARS- CoV-2 BQ and XBB subvariants https://t.co/r05FtHn2pf
@MoritzGerstung @TWenseleers @OmicronData @Tuliodna @EricTopol ❤️
引用文献その2 Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants: Cell https://t.co/JyJRXFRCU0
Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants - PubMed https://t.co/71qm22YZxR
厳しい… Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants: Cell https://t.co/miz7pkL91j
#Cell: #BQ and #XBB subvariants of #SARS-CoV-2 demonstrate dramatically increased ability to evade neutralizing antibodies, even those from people who received the bivalent mRNA booster or who are immunized and had previous breakthrough #Omicron infection. https://t.co/Xy6AZVyV0I https://t.co/xnzVi5nm1i
RT @MarcGozlan: Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants. "Our findings indicate that BQ and XBB su…
RT @MarcGozlan: Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants. "Our findings indicate that BQ and XBB su…
RT @MarcGozlan: Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants. "Our findings indicate that BQ and XBB su…
RT @MarcGozlan: Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants. "Our findings indicate that BQ and XBB su…
RT @MarcGozlan: Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants. "Our findings indicate that BQ and XBB su…
Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants https://t.co/4dQj6f1JH0
RT @MarcGozlan: Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants. "Our findings indicate that BQ and XBB su…
RT @MarcGozlan: Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants. "Our findings indicate that BQ and XBB su…
@Debunk_the_Funk @BioAnon_1vy_ @ZombyWoof2022 @EduEngineer @profnfenton And this preprint from a Columbia University group. "Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants" Looks like they come to a similar conclusion. https://t.co/FdBcd5UhSH https://t.co/cU9MsBIurR
RT @CellPressNews: "Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants" @CellCellPress https://t.co/nsmXIC0z…
Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants https://t.co/qYqFzk3oF7
Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants | bioRxiv https://t.co/ixPuh4omJg
RT @MarcGozlan: Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants. "Our findings indicate that BQ and XBB su…
RT @MarcGozlan: Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants. "Our findings indicate that BQ and XBB su…
Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants: https://t.co/ijoHbNiAXy
RT @MarcGozlan: Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants. "Our findings indicate that BQ and XBB su…
RT @MarcGozlan: Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants. "Our findings indicate that BQ and XBB su…
RT @MarcGozlan: Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants. "Our findings indicate that BQ and XBB su…
Gupta claims the the bivalent offers protection against XBB variant. What about peer reviewed studies all of which show XBB evades mRNA induced antibodies? https://t.co/jIHiH5EnB8 https://t.co/xyFUw4lvzP https://t.co/GZ2MKtiieG https://t.co/0z1hinT5Kf https://t.co/KoQMHBpE9E
RT @JeanneBartram: @chrischirp https://t.co/fCXjpBoMUu
RT @JeanneBartram: https://t.co/fCXjpBof4W
https://t.co/fCXjpBof4W
@chrischirp https://t.co/fCXjpBoMUu
"Hier berichten wir, dass die Neutralisierung von BQ.1, BQ.1.1, XBB und XBB.1 durch Seren von geimpften und infizierten Personen deutlich beeinträchtigt war, einschl. Seren von Personen, die mit einem bivalenten mRNA-Impfstoff WA1/BA.5 geboostert wurden." https://t.co/J6F1Y3huWv
コロナの新しいBQ変異株とXBB変異株，ちょっとヤバそうですね．現行のワクチンが効きにくいようです． Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants https://t.co/QO9SxjLiPe
@PoorWorkHabits @kiwimacahau @drsimonegold It's also worth looking at the age breakdown and # of days post vaxx/infection among the members of each cohort. https://t.co/4a8oFGsOLs
Ogni variante è più aggressiva per i vaccinati. in molti studi non si tiene conto dei non vaccinati perché si noterebbe che per loro è meno di un'influenza, come accadeva con le prime varianti di omicron @alposto @1V4vendetta https://t.co/FLUjjrPERv
Alarming immune escape of XBB variant: • BQ.1, BQ.1.1, XBB, and XBB.1 are the most resistant SARS-CoV-2 variants to date • Serum neutralization was markedly reduced, including with the bivalent booster https://t.co/nNeeZDxSEV
@PrestonTsao @EricTopol Your question is addressed by Wang et al, “Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants”, Cell, https://t.co/XBgdxhFsiZ. See in particular the beginning of the Discussion section.
RT @wolfeagle1989: @gianlucac1 And how much of the recent lower COVID-19 acute death rate has been due to use of monoclonal antibodies that…
@yunlong_cao Looks like your results have been confirmed https://t.co/PKWWrWkEwp
A paper out in Cell that confirms @yunlong_cao et al's work from October Re: BQ & XBB antibody evasion. Previously: Tweet 702 https://t.co/PKWWrWkEwp /726
RT @Nemasoil: @VPrasadMDMPH https://t.co/HNQM06FfGb. This paper shows that the vaccines are not effective against the new variants.
@VPrasadMDMPH https://t.co/HNQM06FfGb. This paper shows that the vaccines are not effective against the new variants.
@tanyalewis314 By the way, after like 5 or more vaccines you got, you still got Covid. That does not speak well of the vaccines. See this paper, vaccines are not working almost at all for the new variants. https://t.co/HNQM06FfGb
RT @SJWimalawansa: SARS-CoV-2 Subvariants are rapidly spreading. BQ.1, BQ.1.1, XBB, & XBB.1 sera from vaccinated, infected persons, & boost…
SARS-CoV-2 Subvariants are rapidly spreading. BQ.1, BQ.1.1, XBB, & XBB.1 sera from vaccinated, infected persons, & boosted with WA1/BA.5 mRNA vaccines/ antibodies have lost the capacity to neutralize viruses. Immune EVASION is due to new Spike mutations. https://t.co/AtphuT6asX
RT @KarabaAdam: Once again, the neutralization of new variants of SARS-CoV2, especially BQ & XBB sub-lineages. This article in the cell con…
Once again, the neutralization of new variants of SARS-CoV2, especially BQ & XBB sub-lineages. This article in the cell confirms, it might be serious
@gianlucac1 And how much of the recent lower COVID-19 acute death rate has been due to use of monoclonal antibodies that are no longer effective against the newer variants like BQ.1 and XBB? See Wang et al https://t.co/XBgdxhFsiZ
https://doi.org/10.1016/j.jtho.2022.12.018. Shobana Anpalakhan, Prerana ... (2024) 'Pro-survival roles for p21(Cip1/Waf1) in non-small cell lung cancer', British ...
doi: 10.1016/j.jaci.2024.12.1069. PMID: 39709031. Mehta P, Pan Z, Furuta GT, Kliewer K; Consortium of Eosinophilic Gastrointestinal Disease Researchers.
Ask in the comments! doi.org/10.1016/j.ajcnut.2022.12.018 ... original sound - dayleenjennifier. 264Likes. 46Comments. 108Shares. Trump's Cell ...
2022.11.031 8. https://doi.org/10.1016/j.enganabound. 2022.12.018 9. https://doi.org ...
Cell. 2023;186(2):279–86.e8. Epub 2022/12/30. doi: 10.1016/j.cell.2022.12.018 pmid:36580913. 67. Bruel T, Hadjadj J, Maes P, Planas D, Seve ...
... cell infiltration. Found. American Journal of Transplantation. https://doi.org/10.1016/j.ajt.2022.12.018 · https://www.sciencedirect.com/science ...
Cell. doi: https://doi.org/10.1016/j.cell.2022.12.018 https://www.cell.com/cell/fulltext/S0092-8674(22)01531-8. Currently rated 4.4 by 14 ...
” Cell, December. https://doi.org/10.1016/j.cell.2022.12.018. https://www.cell.com/cell/fulltext/S0092-8674(22)01531-8?_returnURL. Article ...
M無
P
C
MA
JM
MM
RE
す
T
MP
AT
笹
A
ホ
D
君
ニ
ほ
H真
マ
な
SS
JM
F
SC
KN
DC
陰D
WW
R
L
S
L
S
M
HS
LD
S
花
MG
P
T
S
MA
IA
A
S
C
M
旅T
FF
RM
DS
AO
MK
W
AZ
JP
J
KJ
MM
D
CL
E
JM
J
JS
PC
A
T
T
DS
H
HD
DT
CL
DB
PM
G
CM
LP
C
CF
CG
HB
DF
DD
RS
RR
L
PM
B
AH
VP
SW
CX
C
AG
MT
DM
JV
OP
S
DP
B
JD
PB
MS
AF
MB
JL
C
E
A
SC
A
IS
化平
N
M
EG
温
M
LZ
PM
S
LG
もB
C
B
ち
渡
ふ
PB
HS
人感
つ
フ
し
ま
U
夢こ
A
L
CS
G
RH
SN
P
森
菁
H
M
B
DF
SJ
MS
M
三
P
N
Q
B
K
A
B
GF
V
LL
LC
S
仮
GA
DE
SM
AU
ES
CE
MD
SP
KK
AK